Conditioned Pain Modulation in Women With Irritable Bowel Syndrome

Abstract

Evidence suggests that patients with irritable bowel syndrome (IBS) are more vigilant to pain-associated stimuli. The aims of this study were to compare women with IBS (n = 20) to healthy control (HC, n = 20) women on pain sensitivity, conditioned pain modulation (CPM) efficiency, and salivary cortisol levels before and after the CPM test and to examine the relationship of CPM efficiency with gastrointestinal pain, somatic pain, psychological distress symptoms, and salivary cortisol levels in each group. Women, aged 20–42 years, gave consent, completed questionnaires, and kept a symptom diary for 2 weeks. CPM efficiency was tested with a heat test stimulus and cold water condition stimulus in a laboratory between 8 and 10 a.m. on a follicular phase day. Salivary cortisol samples were collected just before and after the experimental testing. Compared to the HC group, women with IBS reported more days with gastrointestinal and somatic pain/discomfort, psychological distress, fatigue, and feeling stressed. During the CPM baseline testing, women with IBS reported greater pain sensitivity compared to the HC group. There was no significant group difference in salivary cortisol levels nor in CPM efficiency, though a post-hoc analysis showed a higher prevalence of impaired CPM efficiency among IBS subjects with more severe lower-GI symptoms. In the IBS group, reduced CPM efficiency was associated with daily abdominal pain/discomfort and psychological distress. Overall, women with IBS exhibited an increased sensitivity to thermal stimuli. Impaired CPM was present in a subset of women with IBS.

Keywords

conditioned pain modulation irritable bowel syndrome cortisol female

Get full access to this article

View all access options for this article.

References

Arendt-Nielsen

Sluka

K. A.

Nie

H. L.

(2008). Experimental muscle pain impairs descending inhibition. Pain, 140, 465–471.

Bartley

E. J.

Rhudy

J. L.

(2012). Endogenous inhibition of the nociceptive flexion reflex (NFR) and pain ratings during the menstrual cycle in healthy women. Annals of Behavioral Medicine, 43, 343–351. doi:10.1007/s12160-012-9345-x

Bond

Quinlan

Dukes

G. E.

Mearin

Clouse

R. E.

Alpers

D. H.

(2009). Irritable bowel syndrome: More than abdominal pain and bowel habit abnormalities. Clinical Gastroenterology and Hepatology, 7, 73–79.

Camilleri

(2012). Peripheral mechanisms in irritable bowel syndrome. New England Journal of Medicine, 367, 1626–1635. doi: 10.1056/NEJMra1207068

Campbell

C. M.

France

C. R.

Robinson

M. E.

Logan

H. L.

Geffken

G. R.

Fillingim

R. B.

(2008). Ethnic differences in diffuse noxious inhibitory controls. Journal of Pain, 9, 759–766. doi:S1526-5900(08)00502-6

Cella

Riley

Stone

Rothrock

Reeve

Yount

… Hays

(2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. Journal of Clinical Epidemiology, 63, 1179–1194. doi:10.1016/j.jclinepi.2010.04.011

Chang

Sundaresh

Elliott

Anton

P. A.

Baldi

Licudine

… Mayer

E. A.

(2009). Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterology and Motility, 21, 149–159.

Deechakawan

Cain

K. C.

Jarrett

M. E.

Burr

R. L.

Heitkemper

M. M.

(2012). Effect of self-management intervention on cortisol and daily stress levels in irritable bowel syndrome. Biological Research for Nursing, 15, 26–36. doi:10.1177/1099800411414047

Derogatis

L. R.

(1993). BSI: brief symptom inventory; administration, scoring and procedures manual (4th ed.). Minneapolis, MN: National Computer Systems.

10.

Drossman

D. A.

Corazziari

Delvaux

Spiller

R.C.

Talley

N. J.

Thompson

W. G.

, … Rome III Committees. (2006). Rome III: The functional gastrointestinal disorders (3rd ed.). McLean, VA: Degnon Associates.

11.

Elsenbruch

(2011). Abdominal pain in irritable bowel syndrome: A review of putative psychological, neural and neuro-immune mechanisms. Brain, Behavior, and Immunity, 25, 386–394. doi:10.1016/j.bbi.2010.11.010

12.

Faresjo

Grodzinsky

Johansson

Wallander

M. A.

Timpka

Akerlind

(2007). A population-based case-control study of work and psychosocial problems in patients with irritable bowel syndrome—Women are more seriously affected than men. American Journal of Gastroenterology, 102, 371–379.

13.

Goncalves de Medeiros

M. T.

de Oliveira

R. B.

dos Santos

A. A.

de Leopoldino

D. M.

Lima

M. C.

Nobre

R. A.

Nobre e Souza

M. A.

(2012). The effects of sildenafil on rectal sensitivity and tone in patients with the irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 35, 577–586. doi:10.1111/j.1365-2036.2011.04977.x

14.

Gulewitsch

M. D.

Enck

Hautzinger

Schlarb

A. A.

(2011). Irritable bowel syndrome symptoms among German students: Prevalence, characteristics, and associations to somatic complaints, sleep, quality of life, and childhood abdominal pain. European Journal of Gastroenterology and Hepatology, 23, 311–316. doi:10.1097/MEG.0b013e3283457b1e

15.

Heitkemper

M. M.

Cain

K. C.

Deechakawan

Poppe

Jun

S. E.

Burr

R. L.

Jarrett

M. E.

(2012). Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome. Neurogastroenterology and Motility, 24, 626–631, e270–e271. doi:10.1111/j.1365-2982.2012.01915.x

16.

Heymen

Maixner

Whitehead

W. E.

Klatzkin

R. R.

Mechlin

Light

K. C.

(2010). Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls. Clinical Journal of Pain, 26, 104–109. doi:10.1097/AJP.0b013e3181bff800 00002508-201002000-00004

17.

Hubbard

C. S.

Labus

J. S.

Bueller

Stains

Suyenobu

Dukes

G. E.

… Mayer

E. A.

(2011). Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain. Journal of Neuroscience, 31, 12491–12500. doi:10.1523/jneurosci.1860-11.2011

18.

Johannesson

de Boussard

C. N.

Brodda Jansen

Bohm-Starke

(2007). Evidence of diffuse noxious inhibitory controls (DNIC) elicited by cold noxious stimulation in patients with provoked vestibulodynia. Pain, 130, 31–39. doi:S0304-3959(06)00589-6

19.

Jones

Koloski

Boyce

Talley

N. J.

(2011). Pathways connecting cognitive behavioral therapy and change in bowel symptoms of IBS. Journal of Psychosomatic Research, 70, 278–285.

20.

Keszthelyi

Troost

F. J.

Simren

Ludidi

Kruimel

J. W.

Conchillo

J. M.

Masclee

A. A.

(2012). Revisiting concepts of visceral nociception in irritable bowel syndrome. European Journal of Pain, 16, 1444–1454. doi:10.1002/j.1532-2149.2012.00147.x

21.

King

C. D.

Wong

Currie

Mauderli

A. P.

Fillingim

R. B.

Riley

J. L.

, 3rd. (2009). Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain, 143, 172–178. doi:S0304-3959(08)00765-3

22.

Lovell

R. M.

Ford

A. C.

(2012). Effect of gender on prevalence of irritable bowel syndrome in the community: Systematic review and meta-analysis. American Journal of Gastroenterology, 107, 991–1000.

23.

Magasi

Ryan

Revicki

Lenderking

Hays

R. D.

Brod

… Cella

(2012). Content validity of patient-reported outcome measures: Perspectives from a PROMIS meeting. Quality of Life Research, 21, 739–746. doi:10.1007/s11136-011-9990-8

24.

Naliboff

B. D.

Berman

Suyenobu

Labus

J. S.

Chang

Stains

… Mayer

E. A.

(2006). Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology, 131, 352–365. doi:10.1053/j.gastro.2006.05.014

25.

Normand

Potvin

Gaumond

Cloutier

Corbin

J. F.

Marchand

(2011). Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder. Journal of Clinical Psychiatry, 72, 219–224. doi:10.4088/JCP.08m04969blu

26.

Nyrop

K. A.

Palsson

O. S.

Levy

R. L.

Korff

M. V.

Feld

A. D.

Turner

M. J.

Whitehead

W. E.

(2007). Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Alimentary Pharmacology and Therapeutics, 26, 237–248.

27.

Orr

W. C.

Crowell

M. D.

Lin

Harnish

M. J.

Chen

J. D.

(1997). Sleep and gastric function in irritable bowel syndrome: Derailing the brain-gut axis. Gut, 41, 390–393.

28.

Ossipov

M. H.

Dussor

G. O.

Porreca

(2010). Central modulation of pain. Journal of Clinical Investigation, 120, 3779–3787.

29.

Piche

Bouin

Arsenault

Poitras

Rainville

(2011). Decreased pain inhibition in irritable bowel syndrome depends on altered descending modulation and higher-order brain processes. Neuroscience, 195, 166–175. doi:S0306-4522(11)00982-1

30.

Rezaii

Hirschberg

A. L.

Carlstrom

Ernberg

(2012). The influence of menstrual phases on pain modulation in healthy women. Journal of Pain, 13, 646–655. doi:10.1016/j.jpain.2012.04.002

31.

Sandler

R. S.

(1990). Epidemiology of irritable bowel syndrome in the United States. Gastroenterology, 99, 409–415.

32.

Spiegel

Strickland

Naliboff

B. D.

Mayer

E. A.

Chang

(2008). Predictors of patient-assessed illness severity in irritable bowel syndrome. American Journal of Gastroenterology, 103, 2536–2543. doi:10.1111/j.1572-0241.2008.01997.x

33.

Tillisch

Mayer

E. A.

Labus

J. S.

(2011). Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology, 140, 91–100. doi:10.1053/j.gastro.2010.07.053

34.

Tousignant-Laflamme

Marchand

(2009). Excitatory and inhibitory pain mechanisms during the menstrual cycle in healthy women. Pain, 146, 47–55. doi:S0304-3959(09)00341-8

35.

Trimble

Johnson

A. C.

Foster

Greenwood-van Meerveld

(2007). Corticotropin-releasing factor receptor 1-deficient mice show decreased anxiety and colonic sensitivity. Neurogastroenterology and Motility, 19, 754–760.

36.

van Wijk

Veldhuijzen

D. S.

(2010). Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. Journal of Pain, 11, 408–419. doi:10.1016/j.jpain.2009.10.009

37.

Williams

D. A.

Clauw

D. J.

(2009). Understanding fibromyalgia: Lessons from the broader pain research community. Journal of Pain, 10, 777–791.

38.

Wong

Rodrigues

A. C.

King

C. D.

Riley

J. L.

3rd Schmidt

Vierck

C. J.

Mauderli

A. P.

(2010). Relationships between irritable bowel syndrome pain, skin temperature indices of autonomic dysregulation, and sensitivity to thermal cutaneous stimulation. Pain Research and Treatment, 2010, 949027. doi:10.1155/2010/949027

39.

Yarnitsky

(2010). Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): Its relevance for acute and chronic pain states. Current Opinion in Anesthesiology, 23, 611–615. doi:10.1097/ACO.0b013e32833c348b

40.

Yarnitsky

Arendt-Nielsen

Bouhassira

Edwards

R. R.

Fillingim

R. B.

Granot

… Wilder-Smith

(2010). Recommendations on terminology and practice of psychophysical DNIC testing. European Journal of Pain, 14, 339. doi:10.1016/j.ejpain.2010.02.004